drugset / Trial / NCT01942915

Umbilical Cord Blood Mononuclear Cells Therapy in Liver Cirrhosis

NCT01942915

Phase 1 Unknown 10 enrolled Hebei Medical University
NaSingle-groupOpen-labelTreatment

Summary

This study is to evaluate the safety and efficacy of umbilical cord blood mononuclear cells transplantation in liver cirrhosis patients.

Timeline

Start
2012-01
Primary completion
2013-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Umbilical cord blood mononuclear cells Cell therapy Other

Indications